InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the full record of transactions filed by Adimab, LLC. Officer active across 2 companies, notably Adagio Therapeutics, Inc.. Cumulatively, 3 disclosures have been logged. Breakdown: 0 buy · 1 sell. Total volume traded: €18.2m. Activity tracked since 19 January 2024. The latest transaction was filed on 19 January 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Adimab, LLC is a declarant linked to Adagio Therapeutics, Inc. and Invivyd, Inc. Across 4 filings, the sampled recent filings run from 2021-08-12 to 2024-01-22, with 0 in purchases and 18154003 EUR in sales; the most recent concerns Invivyd, Inc. and a sale of 18154002.69578845 EUR.